INS and Hypoglycemia: The effects of DA on insulin secretion in vitro and the observed postprandial excursions support the hypothesis that gut-derived L-DOPA and DA delivered via the circulation impact insulin secretion and postprandial glucose levels, perhaps in defense against hypoglycemia.